Amount$10M
SeriesSeries C
AnnouncedMay 6, 2024
Time since last round277 mo
SectorLife Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody
Sub-sectorArtificial Intelligence
Weak
A weak or unusual round versus its peers.
Round size vs peers
Far below the typical Series C round — well under the median.
Syndicate size
Single investor — limited external validation.
Insider conviction
All-new money — no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series C rounds (999)
Round size distribution8th pct
smaller Series C roundslarger
vs. Life Sciences, Immunotherapy, Immunology, Cancer, Cancer Immunotherapy, Antibody (6)
Round size in sector67th pct
$3Mthis round: $10M$25M
